Pharma solutions

Cell and gene therapy

Your therapy can make all the difference. Together, we'll unlock its potential.

Accelerating healthier futures

As healthcare advances, so must the processes that connect patients to the therapies they need. Each patient's path to treatment is unique. And because a rapidly evolving cell and gene therapy industry requires an equally innovative partner, Cencora is committed to delivering solutions that enable this connection.
Three medical professionals looking over paperwork together. One person, wearing a purple suit jacket, holds the paperwork in one hand and a pen in the other. The other two people are wearing white jackets and stethoscopes.

For therapy developers

Distribution and commercialization services

From pre-clinical and commercial logistics to distribution and order-to-cash solutions, our experts help find the right options for your therapy. We’ve served patients for clinical trials and commercial distribution in more than 50 countries worldwide.

For providers

Market access and reimbursement

We’ve helped commercially support most of the cell and gene therapies on the market today. Our experts offer market access, reimbursement, and specific therapeutic area insights to help therapy developers understand the unique market landscape.

For patients

Impacting patient support

Hub services provide a holistic and comprehensive approach to ongoing patient support. We have the flexibility to design unique programs incorporating a full array of access, adherence, and affordability solutions that meet patient needs.

Meet with us live

Connect with experts at cell and gene industry events.
A Cencora trade show booth displaying illegible information on monitor screens and on vertical banners. A desk with the Cencora logo is in the foreground. A coffeemaker, cups, and cookies sit on the desk alongside promotional brochures.

Improving connectivity across CGT treatment journeys to enable enhanced patient and provider experience

With the launch of the CGT Integration Hub, which is platform-agnostic and powered by Cencora’s innovative customer relationship management (CRM) system, we can complete platform integrations with various supply chain partners, including therapy developers and CGT software providers. For example, we recently completed a platform integration with TrakCel’s cell orchestration platform OCELLOS.

Working together with therapy developers to identify and overcome barriers

We approach every touchpoint along the cell and gene therapy commercialization and treatment timeline with the patient in mind. When we all collaborate to deliver potentially life-saving solutions, we can start redefining the moments that matter for patients, clinicians, and our key stakeholders.

  • Complete data solutions provide visibility to the patient journey
  • Innovative patient access, affordability, and adherence solutions unique to cell and gene therapies
  • Evidence-based resources and information exchange between biopharma companies and healthcare payers
  • Expert guidance on market access, reimbursement, and policy
  • Complete logistics support, from pre-clinical through clinical trials to commercialization and post-launch solutions to ensure product quality standards are maintained
  • Established relationships with thousands of healthcare providers optimizes the order-to-cash process and ease of product access
Three medical professionals (a light-skinned doctor standing holding a laptop, a dark-skinned person in business clothing holding a tablet device, and a light-skinned nurse in scrubs) having a conversation in a doctor’s office.
A light-skinned person and a dark-skinned person, both dressed in professional business attire, sitting across from each other in a bright conference room.
A light-skinned doctor in a white lab coat sitting with a light-skinned patient wearing a purple sweater. The doctor is consulting with the patient in a bright hospital room while holding a clipboard.
Lung-I Cheng, a gentleman with short, dark hair, wearing a blue dress shirt and gray suit jacket is sitting at a conference table, speaking with attendees of a cell and gene therapy event.
Lung-I Cheng, a gentleman with short, dark hair, wearing a blue dress shirt and gray suit jacket is sitting at a conference table, speaking with attendees of a cell and gene therapy event.
"Cencora has a proven history of bringing complex and transformative therapies to market. But like our cell and gene therapy partners, we're always looking ahead. We want to innovate because there will be new challenges as the field evolves. We are committed to co-creating innovative solutions to meet those challenges."

Lung-I Cheng
Vice President, Head of Cell & Gene Therapy
Lung-I Cheng, a gentleman with short, dark hair, wearing a blue dress shirt and gray suit jacket is sitting at a conference table, speaking with attendees of a cell and gene therapy event.

Let's work together to envision new paths to healthier futures around the world

Two people engaging in discussion in a bright room. One person wears glasses and a white lab coat over a blue collared shirt. The second wears a dark suit jacket over a pink button-up shirt.

Our partnerships 

Collaboration is essential to the creation of clinical and commercial scale logistics platforms. To support therapy developers, we have integrated systems and technology with a number of key partner organizations. 
Four people standing during a discussion in a bright room. They each wear business-casual clothing. A person with shoulder-length blonde hair holds a stack of papers.

Pharma Solutions

Each investment we make is focused on connecting healthcare stakeholders to accelerate healthier futures. Our unrivaled expertise powers us in our vision to help you fully realize your product’s power—through the patients it reaches and the strategic outcomes it delivers. Learn more about our end-to-end suite of commercialization solutions for biopharma companies. 

Cell and gene therapy insights

CGT cells

Insight

Our global advanced therapy medical product charging stations and capabilities — 2024 Q1 update

Andrea Zobel
AmerisourceBergen
May 2024

Insight

Infographic: Exploring the landscape, modalities, and logistics of cell and gene therapies

World Courier
AmerisourceBergen
January 2024

Cell and gene therapy insights

Insight

Streamlining Patient Access to Cell and Gene Therapies


AmerisourceBergen
December 2023

Connect with our cell and gene therapy team

Schedule some time with our cell and gene therapy experts today. We look forward to hearing from you.